Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Combined Methotrexate and Escitalopram in Psoriasis with Depression/Anxiety
NCT07432815Phase 4Completed
- Sponsor
- Cairo University
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in psoriasis, major depressive disorder (MDD), anxiety disorder, sponsored by Cairo University. Started Feb 2026; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
psoriasismajor depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT07432815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432815.